Development of Lung Vibration Equipment
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 25
- 试验地点
- 2
- 主要终点
- Systolic blood pressure
研究概览
简要总结
This study designed a portable and easily accessible lung vibration device that is simple to use and can operate with both a battery system and a charging system for greater convenience. It helps enhance the effectiveness of mucus drainage, prevents complications, and reduces both the duration and cost of hospital treatment.
详细描述
Lung vibration device uses a motor as the power source to generate vibrations and has a shape similar to an iron. It is connected by an electrical cord in this section and can operate using either a battery system or a charging system. It features a vertically aligned handle perpendicular to the main body for a firm grip. The base of the device has a sponge head to absorb shock from the vibration during use, which is removable. The on/off switch is located at the end of the handle. This device uses 220-volt alternating current. The unit weighs approximately 1.1 kilograms and is made of strong and durable plastic.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- None
盲法说明
Masking will not be employed in this crossover study, as both participants and investigators will be aware of the intervention administered in each period.
入排标准
- 年龄范围
- 18 Years 至 59 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female
- •Aged 18-59 years
- •Inpatients at Burapha University Hospital, Mueang District, Chonburi Province, with pulmonary secretion retention
- •Referred by their attending physician for enhanced secretion clearance through physical therapy methods
排除标准
- •Having inflamed wounds on the chest or back
- •Having unstable vital signs, defined as: resting heart rate <60 or >100 beats per minute; blood pressure <90/60 or >120/80 mmHg; respiratory rate <12 or >20 breaths per minute; oxygen saturation <95%; and body temperature >37°C
- •Having a bleeding tendency, defined as a platelet count <20,000 per cubic millimeter
- •Taking medications that increase bleeding risk within 7 days prior to participation, including: Anticoagulants (such as Warfarin, Dabigatran, Rivaroxaban, Apixaban, Edoxaban), Antiplatelet agents (such as Aspirin, Clopidogrel, Dipyridamole, Prasugrel, Ticagrelor)
- •Having an International Normalized Ratio (INR) >1.1 for those not on anticoagulants, and >3.0 for those on anticoagulants
- •Having subcutaneous emphysema
- •Experiencing severe hemoptysis (coughing up blood)
- •Having chest wall pain
- •Having acute spinal cord injury, rib fractures, or conditions associated with high fracture risk
- •Having skin grafts or burn wounds
- •Being admitted to intensive care units (ICU, RICU, or CICU)
- •Having untreated pneumothorax
- •Having an acute inflammatory process of the respiratory system
- •Having inflammatory or infectious conditions such as tuberculosis, lung abscess, or COVID-19
- •Having respiratory diseases that are contraindications or precautions for lung vibration, including COPD, uncomplicated pneumonia, asthma, lung cancer, or metastatic cancer
结局指标
主要结局
Systolic blood pressure
时间窗: Baseline (0 minutes) and immediately post-intervention (30 minutes)
Systolic blood pressure will be measured in mmHg unit
Diastolic blood pressure
时间窗: Baseline (0 minutes) and immediately post-intervention (30 minutes)
Diastolic blood pressure will be measured in mmHg unit
Body temperature
时间窗: Baseline (0 minutes) and immediately post-intervention (30 minutes)
Body temperature will be measured in degree Celsius
Oxygen saturation
时间窗: Baseline (0 minutes) and immediately post-intervention (30 minutes)
Partial pressure of oxygen saturation will be measured in percent
Sputum
时间窗: Immediately post-intervention (30 minutes)
Sputum will be measured for its quantity in ml unit and quality using photograph
次要结局
未报告次要终点
研究者
Piyapong Prasertsri
Associate Professor Dr.
Burapha University